Eye Diseases Completed Phase 1 Trials for Dorzolamide (DB00869)

IndicationStatusPhase
DBCOND0030511 (Eye Diseases)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02967614KJ-TFC-004 Drug-drug Interaction StudyTreatment